Pomdoctor Statistics
Total Valuation
Pomdoctor has a market cap or net worth of $6.56 million. The enterprise value is $70.97 million.
| Market Cap | 6.56M |
| Enterprise Value | 70.97M |
Important Dates
The next estimated earnings date is Tuesday, November 3, 2026, after market close.
| Earnings Date | Nov 3, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Pomdoctor has 7.73 million shares outstanding. The number of shares has increased by 267.39% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 7.73M |
| Shares Change (YoY) | +267.39% |
| Shares Change (QoQ) | +106.82% |
| Owned by Insiders (%) | 18.59% |
| Owned by Institutions (%) | 0.34% |
| Float | 3.73M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.12 |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.18 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.35
| Current Ratio | 0.35 |
| Quick Ratio | 0.27 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -26.96 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -352.09% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 250.75% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | $366,204 |
| Profits Per Employee | -$330,184 |
| Employee Count | 165 |
| Asset Turnover | 6.84 |
| Inventory Turnover | 59.66 |
Taxes
In the past 12 months, Pomdoctor has paid $9,938 in taxes.
| Income Tax | 9,938 |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 0.87 |
| 200-Day Moving Average | 3.32 |
| Relative Strength Index (RSI) | 47.08 |
| Average Volume (20 Days) | 26,839 |
Short Selling Information
The latest short interest is 18,268, so 0.04% of the outstanding shares have been sold short.
| Short Interest | 18,268 |
| Short Previous Month | 19,419 |
| Short % of Shares Out | 0.04% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 1.05 |
Income Statement
In the last 12 months, Pomdoctor had revenue of $60.42 million and -$54.48 million in losses. Loss per share was -$9.02.
| Revenue | 60.42M |
| Gross Profit | 7.25M |
| Operating Income | -49.76M |
| Pretax Income | -55.70M |
| Net Income | -54.48M |
| EBITDA | -49.73M |
| EBIT | -49.76M |
| Loss Per Share | -$9.02 |
Balance Sheet
The company has $1.86 million in cash and $66.27 million in debt, with a net cash position of -$64.41 million or -$8.33 per share.
| Cash & Cash Equivalents | 1.86M |
| Total Debt | 66.27M |
| Net Cash | -64.41M |
| Net Cash Per Share | -$8.33 |
| Equity (Book Value) | -74.51M |
| Book Value Per Share | -8.96 |
| Working Capital | -20.19M |
Cash Flow
In the last 12 months, operating cash flow was -$18.41 million and capital expenditures -$213,073, giving a free cash flow of -$18.62 million.
| Operating Cash Flow | -18.41M |
| Capital Expenditures | -213,073 |
| Depreciation & Amortization | 31,126 |
| Net Borrowing | -662,994 |
| Free Cash Flow | -18.62M |
| FCF Per Share | -$2.41 |
Margins
Gross margin is 12.00%, with operating and profit margins of -82.35% and -90.16%.
| Gross Margin | 12.00% |
| Operating Margin | -82.35% |
| Pretax Margin | -92.19% |
| Profit Margin | -90.16% |
| EBITDA Margin | -82.29% |
| EBIT Margin | -82.35% |
| FCF Margin | n/a |
Dividends & Yields
Pomdoctor does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -267.39% |
| Shareholder Yield | -267.39% |
| Earnings Yield | -780.91% |
| FCF Yield | -266.89% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 22, 2026. It was a reverse split with a ratio of 1:18.
| Last Split Date | Jun 22, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:18 |
Scores
Pomdoctor has an Altman Z-Score of -60.03 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -60.03 |
| Piotroski F-Score | 2 |